Answers are grounded in this paper and cite their sources.
Background Bone tissue engineering requires porous scaffold systems that combine sufficient mechanical stability, controlled degradation, and favorable biological response. Graphene oxide (GO) is a promising nanoreinforcement because of its high surface area, oxygen-containing functional groups, and ability to interact with polymeric and ceramic scaffold phases. Methods In this study, GO-reinforced hydroxyapatite/chitosan/polycaprolactone (HA/CS/PCL) biocomposite scaffolds were fabricated by solvent casting followed by freeze-drying. GO was incorporated at 0, 0.5, 1.0, 1.5, and 2.0 wt% relative to total solids. The scaffolds were evaluated for morphology, porosity, swelling, degradation, compressive strength, elastic modulus, antibacterial response, protein adsorption, and in vitro cell viability. Finite element analysis was additionally used to examine stress distribution and load-transfer behavior under quasi-static compression. Results Controlled GO incorporation improved scaffold mechanical and biological performance compared with the unreinforced scaffold. The 1.5 wt% GO scaffold showed the most balanced response, with increased compressive strength, higher elastic modulus, enhanced cell viability, improved protein adsorption, and stronger antibacterial activity. At 2.0 wt% GO, performance decreased slightly, likely because of partial nanosheet agglomeration and less uniform stress transfer. Conclusion The findings indicate that optimized GO loading can enhance HA/CS/PCL scaffold performance for bone tissue-engineering research. However, osteogenic differentiation assays, long-term degradation studies, and in vivo validation are still required before translational or load-bearing orthopedic applicability can be confirmed.
No takes yet. Share an insight, caveat, or question.
Padhi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: